Cholesterol Degrading Platform by Repair Biotechnologies

We reverse atherosclerosis

The first-in-class Cholesterol Degrading Platform (CDP)

Repair Biotechnologies develops the Cholesterol Degrading Platform, a safe approach to treating medical conditions that arise due to localized accumulations of excess cholesterol. In particular, our treatments can rapidly and dramatically reduce atherosclerotic plaque in arteries, the cause of stroke, heart attack, and other cardiovascular disease.

CDP will treat many conditions.

The Cholesterol Degrading Platform can be tailored to many indications and delivery mechanisms. A therapy to reverse atherosclerosis is the first compelling demonstration of its broader potential.


After decades of research and blockbuster drugs, the largest cause of human mortality remains cardiovascular disease. More than 5 million people die every year due to the buildup of atherosclerotic plaque.

We aim to remove that plaque.

Read the latest news and updates